GC Green Cross Surpasses 400 Million Doses in Cumulative Production of 'GC Flu'

400 Million Vaccinated Worldwide
Commitment to Sustained Global Competitiveness

GC Green Cross announced on September 18 that the cumulative production volume of its flu vaccine, 'GC Flu,' has surpassed 400 million doses. One dose is equivalent to a single adult vaccination, meaning that 400 million people worldwide have received the GC Green Cross flu vaccine.

GC Green Cross's flu vaccine 'GC Flu'. GC Green Cross

The influenza virus occurs globally and spreads every winter in countries with distinct seasonal epidemics. In South Korea, flu outbreaks are typically concentrated in the fourth quarter, so GC Green Cross begins shipping its flu vaccine from the third quarter to ensure stable product supply. The company stated that it firmly maintains the number one market share for flu vaccines in South Korea based on production volume.

Additionally, by securing stable export volumes to the Southern Hemisphere, where the seasons are the opposite of Korea, GC Green Cross operates its flu vaccine business under a year-round production system. In fact, GC Green Cross has ranked first in market share for 12 consecutive years in the Southern Hemisphere flu vaccine bid organized by the Pan American Health Organization (PAHO), one of the world's largest vaccine buyers, outperforming multinational pharmaceutical companies.

Currently, GC Green Cross has obtained product approval for GC Flu in 25 countries worldwide and supplies it to more than 60 countries.

Lee Inkyu, head of the Hwasun plant, said, "We are enhancing our competitiveness both domestically and internationally based on an optimized production system," adding, "We will continue to solidify our position as a global vaccine manufacturer."

Meanwhile, GC Green Cross is accelerating the development of a high-immunogenicity trivalent flu vaccine for elderly patients aged 65 and older, and plans to submit a domestic Phase 2 clinical trial application (IND) in the first half of next year.

This content was produced with the assistance of AI translation services.